UK markets closed

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
70.57+0.20 (+0.28%)
At close: 04:00PM EDT
70.57 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
131,314
131,314
196,245
241,544
163,562
Cost of revenue
10,512
10,512
52,827
62,176
30,419
Gross profit
120,802
120,802
143,418
179,368
133,143
Operating expenses
Research development
24,537
24,537
36,082
32,105
40,503
Selling general and administrative
52,790
52,790
70,062
46,790
60,012
Total operating expenses
110,981
110,981
140,381
75,517
112,757
Operating income or loss
9,821
9,821
3,037
103,851
20,386
Interest expense
656
656
1,799
19,619
27,415
Total other income/expenses net
46,784
46,784
32,727
-12,913
243
Income before tax
63,660
63,660
36,011
72,205
1,292
Income tax expense
9,841
9,841
41,230
-4,148
-5,306
Income from continuing operations
53,819
53,819
-5,219
76,353
6,598
Net income
52,154
52,154
-33,361
57,138
-2,985
Net income available to common shareholders
52,154
52,154
-33,361
57,138
-2,985
Basic EPS
0.93
3.02
-1.98
3.44
-0.18
Diluted EPS
0.87
2.94
-1.98
3.31
-0.18
Basic average shares
17,154
17,298
16,868
16,630
16,185
Diluted average shares
17,360
17,757
16,868
17,246
16,825